- Home
- SRM vs MBIO Comparison
SRM vs MBIO Comparison
Compare SRM & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- MBIO
- Stock Information
- Founded
- SRM 1979
- MBIO 2015
- Country
- SRM United States
- MBIO United States
- Employees
- SRM N/A
- MBIO N/A
- Industry
- SRM
- MBIO Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- MBIO Health Care
- Exchange
- SRM Nasdaq
- MBIO Nasdaq
- Market Cap
- SRM 9.0M
- MBIO 7.3M
- IPO Year
- SRM 2023
- MBIO N/A
- Fundamental
- Price
- SRM $0.81
- MBIO $1.24
- Analyst Decision
- SRM
- MBIO
- Analyst Count
- SRM 0
- MBIO 0
- Target Price
- SRM N/A
- MBIO N/A
- AVG Volume (30 Days)
- SRM 540.8K
- MBIO 102.5K
- Earning Date
- SRM 05-09-2025
- MBIO 05-14-2025
- Dividend Yield
- SRM N/A
- MBIO N/A
- EPS Growth
- SRM N/A
- MBIO N/A
- EPS
- SRM N/A
- MBIO N/A
- Revenue
- SRM $4,394,659.00
- MBIO N/A
- Revenue This Year
- SRM N/A
- MBIO N/A
- Revenue Next Year
- SRM N/A
- MBIO N/A
- P/E Ratio
- SRM N/A
- MBIO N/A
- Revenue Growth
- SRM N/A
- MBIO N/A
- 52 Week Low
- SRM $0.26
- MBIO $1.01
- 52 Week High
- SRM $1.66
- MBIO $65.00
- Technical
- Relative Strength Index (RSI)
- SRM 79.44
- MBIO 47.58
- Support Level
- SRM $0.54
- MBIO $1.25
- Resistance Level
- SRM $0.66
- MBIO $1.34
- Average True Range (ATR)
- SRM 0.07
- MBIO 0.07
- MACD
- SRM 0.02
- MBIO 0.01
- Stochastic Oscillator
- SRM 99.75
- MBIO 61.54
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.